Welcome to LookChem.com Sign In|Join Free
  • or
Pyrrolidine, 1-[(7-chlorothieno[3,2-b]pyridin-2-yl)carbonyl]-2-(methoxymethyl)-, (2S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

380237-33-2

Post Buying Request

380237-33-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

380237-33-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 380237-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,8,0,2,3 and 7 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 380237-33:
(8*3)+(7*8)+(6*0)+(5*2)+(4*3)+(3*7)+(2*3)+(1*3)=132
132 % 10 = 2
So 380237-33-2 is a valid CAS Registry Number.

380237-33-2Downstream Products

380237-33-2Relevant academic research and scientific papers

Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use

-

, (2008/06/13)

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

BENZOFUSED HETEROARYL AMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS INCLUDING THE SAME, AND METHODS FOR THEIR USE

-

Page 36; 37, (2010/02/04)

The invention relates to compounds represented by the formula I and to prodrugs or metabolites thereof, or pharmaceutically acceptable salts or solvates of said compounds, said prodrugs, and said metabolites, wherein Z, Y, R11 and R14, R15, R16, and R17 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 380237-33-2